GlaxoSmithKline PLC Change of name to GSK plc (6484L)
16 May 2022 - 11:00PM
UK Regulatory
TIDMGSK
RNS Number : 6484L
GlaxoSmithKline PLC
16 May 2022
GSK plc
(the 'Company')
Change of name to GSK plc
The Company today confirms its name has changed from
GlaxoSmithKline plc to GSK plc.
The Company announced the decision to change its name to GSK plc
on 27 April 2022 together with its first quarter 2022 results. This
change has now taken effect.
The London Stock Exchange and the New York Stock Exchange will
reflect the change of name in due course.
Shareholders should note that their shareholdings will be
unaffected by the change of name. Existing share certificates
should be retained as they will remain valid for all purposes and
no new share certificates will be issued.
The ISINs, SEDOLs, CUSIPs and ticker symbols of the Company's
ordinary shares and ADS remain unchanged. The Company's Legal
Entity Identifier (LEI) remains 5493000HZTVUYLO1D793.
V A Whyte
Company Secretary
16 May 2022
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
CANFLFVFEVIRLIF
(END) Dow Jones Newswires
May 16, 2022 09:00 ET (13:00 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024